Advaxis Announces That Its HPV Program Has Been Placed On FDA Clinical Hold
October 06, 2015 at 20:37 PM EDT
Shares of Advaxis are down 27% in after-hours trade after the company announced that the FDA has placed its HPV program on clinical hold due to one patient death.
